(Circulation. 1999;100:II-257.)
© 1999 American Heart Association, Inc.
Thoracic Transplantation and Ventricular Assist Devices |
From the College of Physicians and Surgeons, Columbia University, New York, NY.
Correspondence to David J. Pinsky, MD, Columbia University, College of Physicians and Surgeons, PH 10 Stem, 630 W 168th St, New York, NY 10032. E-mail djp5{at}columbia.edu
| Abstract |
|---|
|
|
|---|
Methods and ResultsConditions that were tested included harvest
inflation pressure (0, 10, or 20 mm Hg), inflation gas
composition (100% N2, room air, or 100% O2),
and storage temperature (4°, 10°, or 15°C). Modified Euro-Collins
solution served as the base preservation solution for all experiments,
with a preservation duration of 4 to 6 hours. Arterial
oxygenation (PaO2,
mm Hg), pulmonary vascular resistance (mm Hg/mL per minute),
recipient survival (%), and graft neutrophil infiltration
(
Abs460 nm/min) were measured 30 minutes after
transplantation of the left lung and exclusion of the right lung from
the circulation. All tested conditions significantly affect post-LTX
vascular homeostasis. Inflation at 10 mm Hg pressure preserved
lungs significantly better than did other pressures. There was a
tendency for room air to improve all measured variables compared
with 100% N2 or 100% O2 and a significant
improvement in recipient survival with room air storage. Of the 3
storage temperatures investigated, 10°C storage provided the best
preservation in terms of PaO2, graft neutrophil
infiltration, and survival.
ConclusionsWe conclude that storage at 10°C, 10 mm Hg inflation pressure, with room air establishes optimal lung storage conditions with Euro-Collins solution in this rat LTX model. These data suggest that these conditions should be used to evaluate new and potentially improved preservation strategies.
Key Words: grafting lung transplantation
| Introduction |
|---|
|
|
|---|
70% of patients receiving LTX surviving
for 1 year.1 One of the prime impediments to LTX is the
extreme vulnerability of the lungs to ischemic injury during
the ex vivo storage period. The limited ability that currently exists
to preserve the lungs is manifest by an incidence of primary graft
failure as high as
15%.1 To improve current lung
preservation strategies, it is necessary to have a reproducible animal
model in which it is possible to rigorously test the effects of various
perturbations of preservation conditions. The "ideal" physical
conditions under which to store a lung graft ex vivo has been the
subject of study in a number of laboratories. However, ideal conditions
may vary between species and models. Important potential physical
variables that may affect the success of LTX after lung graft
storage include intratracheal inflation pressure, inflation gas
composition, storage temperature, and others. Although each of these
has been investigated in different models, there are no unified
opinions regarding ideal conditions, particularly in a rat LTX model
that has been used in numerous recent investigations.2 3 4
Even in the clinic, there is considerable variability in the storage
conditions that are used for lung grafts. For example, one third of
transplantation centers use 0° to 5°C for storage temperature,
approximately one third use 5° to 10°C, and 1 center reportedly
uses 10° to 15°C. Generally, the donor lungs are ventilated with
100% oxygen before removal and are inflated to approximately two
thirds of the total lung capacity before transport,5
although there is by no means unanimity in clinical practice.
Significant variations are also reported in preservation solution
composition, volume of flush solution infused, use of
prostaglandins or steroids, and composition of the base
preservation solution.6 Given the wide range of
variability in clinical lung preservation strategies, one can imagine
that the variations between preservation conditions in animal models
are even more diverse, which make head-to-head comparisons between
different preservation strategies nearly impossible. The ability of a preservation solution to successfully improve lung preservation is based on the ability of the solution to maintain cellular integrity and viability of the parenchymal tissue as well as its ability to maintain normal vascular homeostatic mechanisms, such as inhibiting leukocyte adhesion, maintaining a relatively selective barrier to the transit of solutes, and displaying an anticoagulant phenotype to the vascular lumen. When these homeostatic mechanisms are disrupted, lung preservation is dismal.3 4 7 The end result of failed preservation is a vasoconstricted and edematous lung graft filled with clot and choked with neutrophils, which becomes a veritable factory for the synthesis of proinflammatory cytokines.
Given this vulnerability, how may physical conditions of lung graft storage be altered to optimize the result after transplantation? There are unique anatomic considerations in the lung that may permit modulating preservation strategy in ways that are not possible with other solid organs. For instance, the dual supply of oxygen (through the bronchial circulation and through inspired air through the trachea) and extremely high diffusing capacity of the lungs make it possible to insufflate the organ with high oxygen concentrations as a potential strategy to improve preservation. Second, because of the unique interface between the alveoli and the circulation, it is possible that high pressure insufflation may inhibit the egress of fluids and solutes into the hollows of the alveolar structures. Finally, although not unique to the lungs, the ex vivo period of storage facilitates manipulation of lung graft storage temperature, which may be important in terms of limiting the formation of microcrystalline ice within cells or which may inhibit the transcription and translation of deleterious proteins (such as adhesion receptors) during or shortly after the period of hypothermic storage. Because of the availability of inbred strains of rats, the high throughput, consistent reproducibility, and relatively limited expense of a rat LTX model, the current studies were undertaken to define optimal physical conditions for lung graft storage in this model. Defining these parameters should facilitate comparison between alternative preservation strategies that are currently in development or that become available in the future.
| Methods |
|---|
|
|
|---|
Graft Implantation
Sex/strain/size-matched rats were anesthetized,
intubated, and ventilated with 100% O2 with the
use of a rodent ventilator (Harvard Apparatus). Orthotopic
left LTX was performed through a left thoracotomy with the use of a
rapid cuff technique for all 3 anastomoses, with warm ischemic
times maintained <5 minutes. The hilar cross-cramp was released,
reestablishing blood flow and ventilation to the transplanted lung. The
right lung was then functionally removed from the recipient 15 minutes
after reperfusion of the left lung by ligating the native right
pulmonary artery (PA). Millar catheters (2F; Millar
Instruments) were introduced into the main PA and left atrium, and a
Doppler flow probe (Transonics) was placed around the main PA. This
model was adopted based on published procedures.8
Measurement of Lung Graft Function
Online hemodynamic monitoring was accomplished
with the use of MacLab and a Macintosh IIci computer. Measured
hemodynamic parameters included PA pressure
(mm Hg) and PA flow (mL/min). Arterial oxygen tension
(PaO2, mm Hg) was measured
during inspiration of 100% O2 with a model ABL-2
gas analyzer (Radiometer A/S). Pulmonary vascular
resistance (PVR) was calculated as (mean PA pressure-left atrium
pressure)/mean PA flow (expressed as mm Hg/mL per minute). After
baseline measurements, the native right PA was ligated and serial
hemodynamic measurements were taken every 5 minutes
until 30 minutes or recipient death. In addition to
hemodynamic measurements, arterial blood
for gas analysis was sampled at baseline and at the final time
point.
Myeloperoxidase Assay
Thirty minutes after ligation of the native right PA, or at the
time of recipient death, transplanted lungs were removed, rinsed
briskly in physiological saline, and snap-frozen in
liquid nitrogen until the time of myeloperoxidase assay, performed as
described previously.9 Change in absorbance at 460 nm was
measured over 1 minute (myeloperoxidase activity was expressed as
Abs 460 nm/min).
Data Analysis
ANOVA was used to compare different conditions, with significant
differences between groups detected with the use of Bonferroni post hoc
comparison. Animal survival data were analyzed by contingency
analysis with the use of the
2
statistic. Values are expressed as mean±SEM, with differences
considered statistically significant at a level of
P<0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
Inflation Gas Composition
In the next set of experiments, the effects of inflation gas
composition on lung preservation efficacy were tested. For these
experiments, lungs were ventilated with either 100%
N2, room air, or 100% O2
before clamping the mainstem bronchus. Subsequent to transplantation,
arterial oxygenation, PVR, myeloperoxidase
activity, and graft survival were measured in the same manner as was
performed in the inflation pressure groups. Arterial
oxygenation, PVR, and leukocyte accumulation in the
room air group tended to be superior to those seen in the 100%
nitrogen and 100% oxygen groups (Table
). When survival of
recipients was examined, the inflation gas composition was shown to
have a significant effect. Those recipients of lungs inflated with room
air exhibited higher survival than those of the nitrogen-inflated
group. Again, a trend was seen toward superiority of room air over
100% oxygen in terms of effects on recipient survival after LTX
(Figure 2
).
Graft Storage Temperature
As a final parameter for investigation, the effects of
storage temperature on lung graft function and recipient survival were
examined. Three temperatures were studied: 4°, 10°, and 15°C.
Arterial oxygenation was by far superior in
the 10°C group (Table
). Posttransplantation PVRs tended to be
lowest in recipients of grafts stored at 10°C, and leukocyte
accumulation was lowest in the 10°C-stored grafts compared with the
other groups (Table
). Survival rate in the 10°C group was
significantly higher than both other temperature groups studied (Figure 3
).
| Discussion |
|---|
|
|
|---|
The current studies identify 3 features of a rat lung storage strategy
(using modified Euro-Collins solution) as optimal; inflation pressure
of 10 mm Hg, inflation gas composition consisting of room air,
and storage temperature of 10°C. These results are largely in
agreement with similar studies in which separate conditions were
examined in other models. For instance, recent reports indicate that
increased ventilation volume during donor lung flush and hyperinflation
during storage provide improved preservation.10 In these
studies, the authors suggest that graft hyperinflation during storage
may be beneficial because it prevents accumulation of serum proteins in
the alveolar space and maintains surfactant activity, thereby improving
early postoperative lung function. It appears that at a
transpulmonary pulmonary pressure gradient of 15 cm
H2O, sufficient oxygen is available from the
airways and alveoli to permit ongoing ATP synthesis in excised canine
lung lobes.11 On the other hand, excessive hyperdistention
of the donor lung may be harmful in that it may increase lung solute
permeability and produce pulmonary microvascular injury and
edema.12 13 Egan14 suggested that there is a
critical inflation pressure (
35 cm H2O),
beyond which the pulmonary epithelium becomes nonselectively
permeable to solutes. Presumably, the increased pore radius at
intercellular junctions caused by excessive stretch at high lung
volumes does not diminish when lung volume is reduced, causing the
pulmonary epithelium to no longer function as an effective
barrier between the circulation and the air space. Hypoinflation
followed by reinflation can also cause persistent atelectasis and
barotrauma,15 which are associated with poor
posttransplantation lung function. These data suggest the reason why in
our model, an intermediate level of inflation pressure was optimal.
The second focus for our studies was the effects of inflation gas composition on lung graft function after transplantation. Theoretically, it would be advantageous to prevent anoxia or the hypoxic component of ischemia because this is associated with significant inflammatory activation of the vascular endothelium (reviewed in Reference 1616 ). In lung tissue, energy consumption remains unchanged until the alveolar PO2 declines to <1 mm Hg.17 Although the oxygen demand of lung cells for energy metabolism is low, oxygen will continue to be consumed when lungs are kept inflated with gas of low oxygen content during storage. Although it is easy to see how sufficient oxygen would improve pulmonary storage, there are theoretical concerns that especially in ischemic microenvironments, an overabundance of oxygen can drive reactions involving the production of reactive oxygen intermediates and cause superoxide-mediated lung injury. One report demonstrated that a free radical scavenger reduced pulmonary capillary permeability when lungs were exposed to 100% oxygen during preservation.18 Given this balance, in the rat LTX model, the optimal inflation gas composition was previously unknown. The current experiments indicate that room air gas provides the optimal balance of oxygen for lung graft storage. In a rabbit model of lung preservation, however, preservation with pure oxygen was superior to room air.19 Although the reason for the discrepancy between this study and ours is unclear, this comparison illustrates the need to ascertain optimal preservation conditions for any given model.
The final condition that we investigated in these studies was the effect of graft storage temperature on posttransplantation lung function. In general, temperatures are lowered during organ storage or during surgical procedures that may produce ischemia (such as cardiopulmonary bypass or cerebral aneurysm clipping) because this is a highly effective and easily reversible way to lower basal metabolism. However, there is a temperature beneath which cells may be injured, perhaps because of the formation of microcrystalline ice or other mechanisms by which cellular membrane structure and function are disrupted.20 In the cardiac21 and hepatic22 transplantation literature, reports indicate that 4°C is a more suitable preservation temperature than higher temperatures (such as 10° to 12°C). In the pancreas, on the other hand, optimal preservation temperature appears to be from 7° to 10°C23 ; in a rat model involving preservation of heart/lung blocks that are reperfused ex vivo, 12°C preservation is optimal24 ; in an ex vivo rabbit lung model, 10°C preservation was superior to both 4° and 15°C.25 Taken together, these data indicate that the optimal storage temperature is organ- and model-specific. One of the reasons for differing temperature optima for different organs may be that that the hypothermic heart, for instance, favors aerobic free fatty acid metabolism21 and thereby requires lower temperatures to prevent oxygen utilization by basal metabolism under preservation conditions in which oxygen is scarce. On the other hand, limited oxygen availability may be less of a problem for the preserved lung because the tracheobronchial tree and alveoli present a substantial air/fluid interface so that oxygen is less scarce and aerobic metabolism may continue to a limited extent.
Although we have identified the conditions of inflation pressure, inflation gas composition, and storage temperature that provide optimal lung graft storage in the model under study, there are caveats that also should be stated. Other studies in large animals use more extended preservation durations, and there are a number of different lung preservation solutions that provide different levels of ischemic protection to the harvested and transplanted lungs (see Reference 2626 for a comparison of several of these in the same rat lung transplantation model). Therefore, although the optimal conditions for lung graft storage we have identified apply to the orthotopic rat left LTX model with ischemic durations in the range used for this study (4 to 6 hours), it must be recognized that "optimal conditions" for lung graft storage are likely to be dependent on the species and model under study as well as the ischemic durations used. When taken in context, the results of the current study should be helpful in defining testing conditions to facilitate the development of improved lung preservation strategies.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2.
Boasquevisque CH, Lee TC, Mora BN, Peterson D, Osburn
WO, Bernstein M, Zhang W, Nieptupski JB, Scheule RK, Cooper JD, Botney
MD, Patterson GA. Liposome-mediated gene transfer to lung allografts.
J Thorac Cardiovasc Surg. 1997;114:783791.
3.
Pinsky DJ, Naka Y, Chowdhury NC, Liao H, Oz MC,
Michler RE, Kubaszewski E, Malinski T, Stern DM. The nitric
oxide/cyclic GMP pathway in organ transplantation: critical role in
successful lung preservation. Proc Natl Acad Sci U S A. 1994;91:1208612090.
4.
Naka Y, Roy DK, Liao H, Chowdhury NC, Michler RE, Oz
MC, Pinsky DJ. cAMP-mediated vascular protection in an orthotopic rat
lung transplantation model: insights into the mechanism of action of
prostaglandin E1 to improve lung preservation. Circ
Res. 1996;79:773783.
5. Davis RD Jr, Pasque MK. Pulmonary transplantation. Ann Surg. 1995;221:1428.[Medline] [Order article via Infotrieve]
6. Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant. 1998;17:525531.[Medline] [Order article via Infotrieve]
7.
Naka Y, Toda K, Kayano K, Oz MC, Pinsky DJ. Failure to
express the P-selectin gene or P-selectin blockade confer early
pulmonary protection after lung ischemia or
transplantation. Proc Natl Acad Sci U S A. 1997;94:757761.
8. Chowdhury NC, Naka Y, Pinsky DJ, Yano OJ, Smith CR, Rose EA, Stern DM, Michler RE, Oz MC. Novel technique of orthotopic lung transplantation in rats in which survival and hemodynamic assessment can be measured independent of the native lung. Surg Forum. 1994;45:268270.
9. Goldblum SE, Wu K-M, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol. 1978;59:19781985.
10. Puskas JD, Hirai T, Christie N, Mayer E, Slutsky AS, Patterson GA. Reliable 30-hour lung preservation by donor hyperinflation. J Thorac Cardiovasc Surg. 1992;104:10751083.[Abstract]
11.
Faridy EE, Naimark A. Effect of distension on
metabolism of excised dog lung. J Appl
Physiol. 1971;31:3137.
12. Dreyfuss D, Basset G, Soler P, Saumon G. Intermittent positive-pressure hyperventilation with high inflation pressure produces pulmonary microvascular injury in rat. Am Rev Respir Dis. 1985;132:880884.[Medline] [Order article via Infotrieve]
13.
Haniuda M, Hasegawa S, Shiraishi T, Dresler CM, Cooper
JD, Patterson GA. Effects of inflation volume during lung preservation
on pulmonary capillary permeability. J Thorac
Cardiovasc Surg. 1996;112:8593.
14.
Egan EA. Response of alveolar epithelial solute
permeability of changes in lung inflation. J Appl
Physiol. 1980;49:10321036.
15. Decampos KN, Keshavjee S, Liu M, Slutsky AS. Optimal inflation volume for hypothermic preservation of rat lungs. J Heart Lung Transplant. 1998;17:599607.[Medline] [Order article via Infotrieve]
16. Pinsky DJ, Yan S-F, Lawson C, Naka Y, Chen J-X, Connolly ES Jr, Stern DM. Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin Cell Biol. 1995;6:283294.[Medline] [Order article via Infotrieve]
17.
Fisher AB, Codia C. Lung as a model for evaluate of
critical intracellular PO2 and
PCO2. Am J Physiol. 1981;241:E47E50.
18.
Haniuda M, Dresler CM, Mizuta T, Cooper JD, Patterson
GA. Free radical-mediated vascular injury in lungs preserved at
moderate hypothermia. Ann Thorac Surg. 1995;60:13761381.
19. Weder W, Harper B, Shimokawa S, Miyoshi S, Date H, Schreinemarkers H, Egan T, Cooper JD. Influence of intraalveolar oxygen concentration on lung preservation in a rabbit model. J Thorac Cardiovasc Surg. 1991;101:10371043.[Abstract]
20. Fuller BJ. Storage of cells and tissues at hypothermic for clinical use: temperature and animal cells. Symp Soc Exp Biol. 1987;41:341362.[Medline] [Order article via Infotrieve]
21. Masters TN, Rovicsek F, Schaper J, Jenkins S, Rice H. Effects of canine donor heart preservation temperature on posttransplant left ventricular function and myocardial metabolism. Transplantation. 1994;57:807811.[Medline] [Order article via Infotrieve]
22. Astarcioglu I, Delautier D, Adam R, Gigou M, Bismuth H, Feldmann G. The influence of the temperature of storage on survival and ultrastructure of transplanted UW-preserved rat liver grafts. Transplantation. 1993;55:230234.[Medline] [Order article via Infotrieve]
23. Lakey JRT, Wang LCH, Rajotte RV. Optimal temperature in short-term hypothermic preservation of rat pancreas. J Heart Lung Transplant. 1991;51:977981.
24. Shiraishi T, Igisu H, Shrakusa T. Effects of pH and temperature on lung preservation: a study with an isolated rat lung reperfusion model. Ann Thorac Surg. 1994;57:639643.[Abstract]
25. Wang L-S, Yoshikawa K, Miyoshi S, Nakamoto K, Hsieh C-M, Yamazaki F, Guerreiro Cardoso PF, Hans-Joachim Schaefers G, Brito J, Keshavjee SH, Patterson A, Cooper JD. The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J Thorac Cardiovasc Surg. 1989;98:333342.[Abstract]
26.
Kayano K, Toda K, Naka Y, Okada K, Oz MC, Pinsky DJ.
Superior protection in orthotopic rat transplantation with cyclic
adenosine monophosphate and nitroglycerin contain preservation
solution. J Thorac Cardiovasc Surg.. 1999;118:135144.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |